Moderna CEO on Vaccines, Mutation Risk

The video discusses Moderna's role in developing mRNA vaccines, including those for RSV and CMV. It highlights the company's efforts in cancer treatment and global manufacturing expansion to prepare for future pandemics. Concerns about virus mutations from China's reopening are addressed, along with strategies to combat vaccine hesitancy. The potential for future lockdowns and rapid vaccine development is also explored.

What are the potential future risks of new pathogens as discussed in the text?

What lessons have been learned from the COVID-19 pandemic regarding vaccine development?

How does the speaker envision the future of vaccine production and distribution?